Laurus Labs Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-09-04 | −3111.94 | +8930.12 |
| 2026-09-03 | −2345.87 | +4977.46 |
| 2026-09-02 | +6688.37 | +2812.98 |
| 2026-09-01 | −7985.88 | +4588.88 |
| 2026-08-31 | −7985.88 | +4588.88 |
Today's Institutional Flow
On 4 September 2026, foreign institutional investors (FIIs) recorded a net cash outflow of ₹‑3,111.94 Cr, while domestic institutional investors (DIIs) injected a net ₹ 8,930.12 Cr into equities. The contrast underscores a sharp divergence in sentiment, with DIIs acting as the primary source of buying pressure today. Overall, the market reflects a net inflow of roughly ₹ 5,818 Cr driven by domestic participation.
Trend vs 5‑Day Average
The FII cash outflow of ₹‑3,111.94 Cr is less severe than the 5‑day average FII outflow of ₹‑3,333.81 Cr, indicating a modest easing of foreign selling pressure. Conversely, the DII cash inflow of ₹ 8,930.12 Cr exceeds the 5‑day average DII inflow of ₹ 4,430.43 Cr, signalling a strengthening domestic buying trend.
F&O Positioning Data
FIIs posted a net **F&O long position of ₹ 374,795 Cr, highlighting a bullish stance in derivatives. Their index futures exposure shows a long‑to‑short ratio of 1.2, suggesting that long contracts marginally outweigh short contracts across the broader market.
Healthcare Sector Flow
The healthcare segment, where Laurus Labs Limited operates, has experienced a recent tilt toward net DII buying, with foreign funds maintaining a modest short‑biased stance, reinforcing the sector’s resilience amid mixed market flows.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04